Geron (GERN) Other Non-Current Assets (2010 - 2026)
Geron's (GERN) quarterly Other Non-Current Assets came in at $5.9 million in Q1 2026, up 47.31% year-on-year from $4.0 million in Q1 2025, and little changed quarter-over-quarter from $5.9 million in Q4 2025.
Geron (GERN) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Geron has disclosed Other Non-Current Assets across 14 years of filings, most recently posting $5.9 million for Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $5.9 million, up 47.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.9 million (up 47.31% YoY), and the FY2025 annual result was $5.9 million, up 45.75% from the prior year.
- Other Non-Current Assets came in at $5.9 million for Q1 2026 at Geron, roughly flat from $5.9 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $6.3 million in Q1 2022 to a low of $2.7 million in Q3 2025.
- The 5-year median for Other Non-Current Assets is $4.7 million (2023), against an average of $4.8 million.
- Across the five-year window, Other Non-Current Assets soared 48.01% in 2022 and slumped 45.95% in 2025, its largest moves.
- Geron's Other Non-Current Assets stood at $5.4 million in 2022, then slipped by 12.84% to $4.7 million in 2023, then fell by 13.16% to $4.1 million in 2024, then surged by 45.75% to $5.9 million in 2025, then decreased by 0.02% to $5.9 million in 2026.
- The last three Other Non-Current Assets figures came in at $5.9 million (Q1 2026), $5.9 million (Q4 2025), and $2.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 5.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.94 Mn |
| Dec 31, 2025 | 5.95 Mn |
| Sep 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 3.15 Mn |
| Mar 31, 2025 | 4.04 Mn |
| Dec 31, 2024 | 4.08 Mn |
| Sep 30, 2024 | 4.93 Mn |
| Jun 30, 2024 | 4.74 Mn |
| Mar 31, 2024 | 4.71 Mn |
| Dec 31, 2023 | 4.70 Mn |
| Sep 30, 2023 | 5.20 Mn |
| Jun 30, 2023 | 4.75 Mn |
| Mar 31, 2023 | 4.69 Mn |
| Dec 31, 2022 | 5.39 Mn |
| Sep 30, 2022 | 5.51 Mn |
| Jun 30, 2022 | 5.70 Mn |
| Mar 31, 2022 | 6.32 Mn |
| Dec 31, 2021 | 4.80 Mn |
| Sep 30, 2021 | 4.88 Mn |
| Jun 30, 2021 | 4.27 Mn |